PMA device
Impella Left Ventricular Support Systems
Abiomed, Inc. · Temporary Non-Roller Type Left Heart Support Blood Pump (OZD, Class III) · First FDA decision Apr 7, 2016, newest Jul 13, 2021Cardiogenic shock
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
58
Naming "Impella"
MAUDE reports
47,795
Brand "Impella", since 2015
PubMed studies
2,732
Mentioning "Impella"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Impella Left Ventricular Support Systems
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Impella Left Ventricular Support SystemsPMA supplement
P140003-S082 · Decided Jul 13, 2021 · 71 days after receipt · Normal 180 Day Track No User Fee
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
- IMPELLA LEFT VENTRICULAR SUPPORT SYSTEMPMA supplement
P140003-S005 · Decided Apr 7, 2016 · 238 days after receipt · Panel Track
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity)Coding analysisReview closedCAG-00285NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Impella", any status and sponsor, newest update first.
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)Pivotal-lookingRecruiting
Supira MedicalNot on our public-company list
NCT07296744 · 358 participants (planned) · Start May 11, 2026 · Primary completion Nov 2027
Device: The Supira System; Impella · For: Coronary Artery Disease; High Risk Percutaneous Coronary Intervention; Interventional Cardiology and 1 more
Sites: Loma Linda, California; Sacramento, California; Thousand Oaks, California · 27 sites in all
University Hospital of CologneAcademic, hospital or other
NCT07655479 · 115 participants (planned) · Start Apr 23, 2026 · Primary completion Oct 2028
Device: Escalation to more capable microaxial flow-pump (Impella 5.5) · For: Cardiogenic Shock Post Myocardial Infarction
Sites: Düsseldorf, Germany; Kiel, Germany; Cologne, Germany
- Left Ventricular Impella Device Real-World Evaluation in Pediatric PatientsActive, not recruiting
Abiomed Inc.Public (JNJ)
NCT07943182 · 60 participants (planned) · Start Dec 3, 2024 · Primary completion Dec 2027
Device: Impella CP with SmartAssist; Impella 5.5 with SmartAssist · For: Cardiogenic Shock; Heart Failure; Acute Decompensated Heart Failure (ADHF) and 2 more
Sites: Phoenix, Arizona; Loma Linda, California; Los Angeles, California · 24 sites in all
55 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Impella", and for the whole product code for context.
This brand
47,795 reports: 18,434 malfunction, 23,300 injury, 6,055 death
Whole product code OZD
46,892 reports: 17,926 malfunction, 23,020 injury, 5,943 death
Newest reports for this brand
- ImpellaMalfunction
1220648-2026-14118 · Received Oct 30, 2026 · Event dated Oct 7, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Material Integrity Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ImpellaMalfunction
1220648-2026-14119 · Received Oct 30, 2026 · Event dated Oct 9, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Material Integrity Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ImpellaMalfunction
1220648-2026-14120 · Received Oct 30, 2026 · Event dated Oct 9, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Material Integrity Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Automated Impella Controller, Packaged. Primary user control interface for the Impella Catheter, catheter-based heart pump.Open, Classified
Z-0208-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0209-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Connect Optical AIC, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0210-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
22 more recall records with a free account
Published research
The most relevant PubMed records for "Impella"[tiab]. The summary above synthesizes these.
- A Review of the Impella Devices.
Zein R, Patel C, Mercado-Alamo A, et al. · Interv Cardiol · 2022Review
- Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
Saito S, Okubo S, Matsuoka T, et al. · J Cardiol · 2024Review
- Interaction between VA-ECMO and Impella.
Au SY, Fong KM, Ng WYG, et al. · J Echocardiogr · 2021
- Impella-Induced Incessant Ventricular Tachycardia.
Kaki A, Subahi A, Shokr M, et al. · Ochsner J · 2019Case Reports
- Impella in Transport: Physiology, Mechanics, Complications, and Transport Considerations.
Gottula AL, Shaw CR, Milligan J, et al. · Air Med J · 2022Review
- Ventricular Unloading Using the ImpellaTM Device in Cardiogenic Shock.
Attinger-Toller A, Bossard M, Cioffi GM, et al. · Front Cardiovasc Med · 2022Review
- Impella RP as Rescue Measure for Pulmonary Embolism With Hemodynamic Compromise.
Lashin H, Spiritoso R · JACC Case Rep · 2019Editorial
- Valvular complications following the Impella device implantation.
Sef D, Kabir T, Lees NJ, et al. · J Card Surg · 2021Review
- Percutaneous Salvage of an Impella Pretzel.
Mathur M, Mohmand-Borkowski A, Harper M, et al. · JACC Case Rep · 2019
- Use of Impella in Patients Listed for Heart Transplantation.
Pahwa S, Dunbar-Matos C, Slaughter MS, et al. · ASAIO J · 2022Research Support, U.S. Gov't, P.H.S.
- Impella: pumps overview and access site management.
Burzotta F, Russo G, Previ L, et al. · Minerva Cardioangiol · 2018Review
- Optimizing anticoagulation for patients receiving Impella support.
Beavers CJ, DiDomenico RJ, Dunn SP, et al. · Pharmacotherapy · 2021Review
Other devices of this type
Also filed under product code OZD.
- Impella 2.5Abiomed, Inc. · PMA 2025
- Impella Ventricular Support SystemsAbiomed, Inc. · PMA 2023
- Impella CP with SmartAssistAbiomed, Inc. · PMA 2025
- Impella 2.5, Impella CP and CP with SmartAssistAbiomed, Inc. · PMA 2023
- Impella 5.5 with SmartAssist, Impella CP with SmartAssist, Purge CassetteAbiomed, Inc. · PMA 2025
- Automated Impella ControllerAbiomed, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.